by GlobeNewsWire | Aug 27, 2015 | Biotech, Globe Newswire, Health, Medical, Medical Stocks, Pharmaceutical
GAINESVILLE, Fla., Aug. 27, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases,...